Telehealth & Digital Health

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?

With a new national certification, Orange Coast Medical Center is raising the bar for heart patient recovery, backed by data showing dramatic life-saving results.

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

Atlanta's World Neuroscience Day Conference returns to explore the brain-heart connection, demystify clinical trials, and empower a growing community.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

CenterWell's major acquisition of MaxHealth adds 82 clinics and 120,000 patients, deepening its hold on Florida's value-based senior care sector.

Alto Neuroscience completes enrollment for a trial of its skin patch drug, ALTO-101, offering new hope for the millions battling cognitive decline in schizophrenia.

Aktiia's Hilo adds sleep and step tracking to its validated blood pressure monitor, promising a holistic view of heart health in a competitive market.

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

Clinical-stage biotech BioVie announces its novel anti-inflammatory drug, bezisterim, will be featured at a key psychiatric conference for its potential.

A landmark partnership brings a vital IT resilience solution to Europe, aiming to keep patient data accessible and clinicians empowered when systems fail.

With over $10M in new funding, Berlin Heals is advancing a novel implant that uses a gentle electrical field to potentially reverse heart failure damage.

A new drug, JIN-A02, shows early promise in overcoming resistance to common lung cancer therapies, even shrinking hard-to-treat brain metastases.

New data reveals Mesoblast's cell therapy Ryoncil dramatically boosts survival in GvHD patients when used early, paving the way for a major adult trial.

Hoag becomes the world's first Center of Excellence in Oncoplastic Surgery, a revolutionary approach merging cancer removal with cosmetic preservation.

A 'world-first' cervical implant from Zavation Medical Products combines two materials to enhance bone growth while maintaining critical imaging capabilities.

A new health tech firm says its unified platform can fix patient confusion and provider burnout. But in a crowded market, can one company truly solve it all?

Amid a national organ shortage, a Virginia organization's use of new tech and community campaigns led to a 27.5% jump in organs transplanted since 2021.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.